141 related articles for article (PubMed ID: 18541273)
1. Eicosapentaenoic acid lowers plasma and liver cholesterol levels in the presence of peroxisome proliferators-activated receptor alpha.
Sugiyama E; Ishikawa Y; Li Y; Kagai T; Nobayashi M; Tanaka N; Kamijo Y; Yokoyama S; Hara A; Aoyama T
Life Sci; 2008 Jul; 83(1-2):19-28. PubMed ID: 18541273
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol-lowering effect of bezafibrate is independent of peroxisome proliferator-activated receptor activation in mice.
Nakajima T; Tanaka N; Sugiyama E; Kamijo Y; Hara A; Hu R; Li G; Li Y; Nakamura K; Gonzalez FJ; Aoyama T
Biochem Pharmacol; 2008 Jul; 76(1):108-19. PubMed ID: 18486101
[TBL] [Abstract][Full Text] [Related]
3. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
[TBL] [Abstract][Full Text] [Related]
4. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation in muscle and liver lipogenic genes: EPA ethyl ester treatment in lean and overweight (high-fat-fed) rats.
Pérez-Echarri N; Pérez-Matute P; Marcos-Gómez B; Marti A; Martínez JA; Moreno-Aliaga MJ
J Nutr Biochem; 2009 Sep; 20(9):705-14. PubMed ID: 18829285
[TBL] [Abstract][Full Text] [Related]
6. A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver.
Knight BL; Hebbachi A; Hauton D; Brown AM; Wiggins D; Patel DD; Gibbons GF
Biochem J; 2005 Jul; 389(Pt 2):413-21. PubMed ID: 15777286
[TBL] [Abstract][Full Text] [Related]
7. The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver.
Stienstra R; Mandard S; Tan NS; Wahli W; Trautwein C; Richardson TA; Lichtenauer-Kaligis E; Kersten S; Müller M
J Hepatol; 2007 May; 46(5):869-77. PubMed ID: 17321000
[TBL] [Abstract][Full Text] [Related]
8. Influence of peroxisome proliferator-activated receptor alpha on ubiquinone biosynthesis.
Turunen M; Peters JM; Gonzalez FJ; Schedin S; Dallner G
J Mol Biol; 2000 Mar; 297(3):607-14. PubMed ID: 10731415
[TBL] [Abstract][Full Text] [Related]
9. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503
[TBL] [Abstract][Full Text] [Related]
10. PPAR alpha mediates transcriptional upregulation of novel organic cation transporters-2 and -3 and enzymes involved in hepatic carnitine synthesis.
Koch A; König B; Stangl GI; Eder K
Exp Biol Med (Maywood); 2008 Mar; 233(3):356-65. PubMed ID: 18296741
[TBL] [Abstract][Full Text] [Related]
11. Regulation of hepatic cholesterol synthesis by a novel protein (SPF) that accelerates cholesterol biosynthesis.
Shibata N; Jishage K; Arita M; Watanabe M; Kawase Y; Nishikawa K; Natori Y; Inoue H; Shimano H; Yamada N; Tsujimoto M; Arai H
FASEB J; 2006 Dec; 20(14):2642-4. PubMed ID: 17077281
[TBL] [Abstract][Full Text] [Related]
12. Decreased peroxisome proliferator-activated receptor alpha gene expression is associated with dyslipidemia in a rat model of chronic renal failure.
Mori Y; Hirano T; Nagashima M; Shiraishi Y; Fukui T; Adachi M
Metabolism; 2007 Dec; 56(12):1714-8. PubMed ID: 17998026
[TBL] [Abstract][Full Text] [Related]
13. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia.
Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609
[TBL] [Abstract][Full Text] [Related]
14. Effects of ovariectomy on PPAR alpha, SREBP-1c, and SCD-1 gene expression in the rat liver.
Paquette A; Wang D; Jankowski M; Gutkowska J; Lavoie JM
Menopause; 2008; 15(6):1169-75. PubMed ID: 18665039
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice.
Hamelet J; Demuth K; Paul JL; Delabar JM; Janel N
J Hepatol; 2007 Jan; 46(1):151-9. PubMed ID: 17030070
[TBL] [Abstract][Full Text] [Related]
16. Eicosapentaenoic acid improves hepatic steatosis independent of PPARα activation through inhibition of SREBP-1 maturation in mice.
Tanaka N; Zhang X; Sugiyama E; Kono H; Horiuchi A; Nakajima T; Kanbe H; Tanaka E; Gonzalez FJ; Aoyama T
Biochem Pharmacol; 2010 Nov; 80(10):1601-12. PubMed ID: 20691165
[TBL] [Abstract][Full Text] [Related]
17. Alteration of Bile Acid and Cholesterol Biosynthesis and Transport by Perfluorononanoic Acid (PFNA) in Mice.
Zhang Y; Zhang Y; Klaassen CD; Cheng X
Toxicol Sci; 2018 Mar; 162(1):225-233. PubMed ID: 29112762
[TBL] [Abstract][Full Text] [Related]
18. Regulation of human hepatocyte gene expression by fatty acids.
Swagell CD; Henly DC; Morris CP
Biochem Biophys Res Commun; 2007 Oct; 362(2):374-80. PubMed ID: 17707340
[TBL] [Abstract][Full Text] [Related]
19. Human liver cholesteryl ester hydrolase: cloning, molecular characterization, and role in cellular cholesterol homeostasis.
Zhao B; Natarajan R; Ghosh S
Physiol Genomics; 2005 Nov; 23(3):304-10. PubMed ID: 16131527
[TBL] [Abstract][Full Text] [Related]
20. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice.
Peters JM; Hennuyer N; Staels B; Fruchart JC; Fievet C; Gonzalez FJ; Auwerx J
J Biol Chem; 1997 Oct; 272(43):27307-12. PubMed ID: 9341179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
